source
- STAT+: Oura goes public, reported $1.2B earnings in its last fiscal yearIn health tech news today, Oura reports a profit, the FDA loses another key digital health leader, and moreSTAT · 19m ago↗ source
- STAT+: FDA approves AstraZeneca breast cancer drugRoivant drug delivers mid-stage results, Moonwalk raises funds to develop longer-lasting obesity drugs, and more biotech newsSTAT · 28m ago↗ source
- STAT+: Pharmalittle: We’re reading about another Novartis trial failure, a Novo Nordisk setback, and moreAn experimental Novartis drug for a rare neuromuscular condition failed to improve muscle function in a pivotal studySTAT · 1h ago↗ source